Medications ›somatropin (recombinant DNA origin)

somatropin (recombinant DNA origin)

RxCUI 314845 precise ingredient

Contraindicated with · 42

Diagnoses15

Prader-Willi Syndrome Critical Illness Abnormalities, Multiple Intellectual Disability Diabetic Retinopathy Diabetic Angiopathies Obesity Overnutrition Overweight Intracranial Hemorrhages Diabetes Mellitus Disease Attributes Hemorrhage Genetic Diseases, Inborn Drug Hypersensitivity

Condition families27

Chromosome Disorders Imprinting Disorders Brain Neoplasms Central Nervous System Neoplasms Retinal Diseases Diabetes Complications Nervous System Neoplasms Neurobehavioral Manifestations Cerebrovascular Disorders Congenital Abnormalities Nutrition Disorders Endocrine System Diseases Brain Diseases Eye Diseases Neoplasms by Site Central Nervous System Diseases Congenital, Hereditary, and Neonatal Diseases and Abnormalities Neurologic Manifestations Vascular Diseases Neoplasms Nutritional and Metabolic Diseases Nervous System Diseases Cardiovascular Diseases Pathologic Processes Pathological Conditions, Signs and Symptoms Drug-Related Side Effects and Adverse Reactions Chemically-Induced Disorders

Indicated for · 49

Diagnoses21

Gonadal Dysgenesis Noonan Syndrome Sex Chromosome Disorders of Sex Development Turner Syndrome Cachexia Dwarfism Weight Loss Body Weight Changes Prader-Willi Syndrome Bone Diseases, Developmental Abnormalities, Multiple Disorders of Sex Development Thinness Intellectual Disability Obesity Overnutrition Overweight Heart Defects, Congenital Body Weight Heart Failure Genetic Diseases, Inborn

Condition families28

Sex Chromosome Disorders Craniofacial Abnormalities Musculoskeletal Abnormalities Chromosome Disorders Imprinting Disorders Urogenital Abnormalities Cardiovascular Abnormalities Gonadal Disorders Neurobehavioral Manifestations Congenital Abnormalities Nutrition Disorders Connective Tissue Diseases Bone Diseases Musculoskeletal Diseases Endocrine System Diseases Congenital, Hereditary, and Neonatal Diseases and Abnormalities Heart Diseases Neurologic Manifestations Nutritional and Metabolic Diseases Male Urogenital Diseases Female Urogenital Diseases Female Urogenital Diseases and Pregnancy Complications Nervous System Diseases Skin and Connective Tissue Diseases Cardiovascular Diseases Urogenital Diseases Signs and Symptoms Pathological Conditions, Signs and Symptoms

MED-RT, published by the VA through NLM. Relationships attach at the ingredient level, not to a specific product or dose.

RADV audits Coding jobs Chart counter Hours & decimal time About Contact Help Terms Privacy

Innova Coding Suite extension — both tools in your browser: Add to Chrome · Add to Edge

InnovaRx — Innova Health Strategies. ICD-10-CM and the CMS-HCC risk adjustment models are published by CMS and NCHS and are in the public domain. Effective date 2026-10-22 travels in the URL, so this link shows anyone exactly what you see.